• COMPANY
    • LEADERSHIP
    • CAREERS
    • NIH GRANT SUPPORT
    • CONTACT US
    • Non Gamstop Casinos
    • Casinos Not On Gamstop
  • TECHNOLOGY
  • APPLICATIONS
    • ALLOSTERIC TARGETS
    • SECONDARY SCREENING & MECHANISM OF ACTION
    • COMPLEX TARGETS
    • TRUBIND AT WORK
      • ION CHANNEL INHIBITORS
      • PPI INTERACTIONS
      • TARGETING GPCRs
      • KINASE INTERACTIONS
  • DRUG DISCOVERY SERVICES
    • Assay Development
    • Secondary Screening
    • Binding Characterization Process
    • PHARMACEUTICAL PROJECTS
  • PRODUCTS
  • LITERATURE
  • NEWS
  • EVENTS
    • On-Demand Webinars
    • Exhibitions
APPLICATIONS COMPLEX TARGETS

Complex Targets

Back Scattering Interferometry (BSI) can be used to interrogate small molecule binding to any type of target, but because it is mass independent and conformation sensitive, it is uniquely suited to studying interactions with large, membrane bound and other complex targets that cannot be effectively characterized using other techniques, for example:

•   GPCRs

•  Ion channels
•  Receptor tyrosine kinases
•  Transporters

•  Transcription factors

•  Intra-membrane proteases

•  Contractile proteins

•  Fibrils

MSI scientists have worked on many complex target problems, developing robust, high-value assays on the BSI technology platform for a variety of clients. The following partial list provides some examples of the pharmaceutical client project targets we have worked on to date.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Please send us an email or give us a call at (615) 938-7050 in North America or +49 (171) 760-4450 in Europe
to find out how MSI can help accelerate your assay development and screening efforts.

APPLICATIONS

  • ALLOSTERIC TARGETS
  • SECONDARY SCREENING & MECHANISM OF ACTION
  • COMPLEX TARGETS
  • TRUBIND AT WORK
    • ION CHANNEL INHIBITORS
    • KINASE INTERACTIONS
    • TARGETING GPCRs
    • PPI INTERACTIONS

ON-DEMAND WEBINARS

  • Interrogating Ligand: Target Interactions Using Back-Scattering Interferometry Yields Mechanistic Insight and Aids in Compound PrioritizationBy MSI on January 26, 2016
  • Review of Recent Publications Featuring Binding Data Produced by MSIBy MSI on January 26, 2016
  • Conformation-Sensitive Assay Detection for Accelerated Drug Discovery ResearchBy MSI on February 10, 2015
  • Evaluation of the MoA of Allosteric Modulators and Its Application to Drug Discovery using Back-Scattering InterferometryBy MSI on November 13, 2014
  • Using BSI to Investigate Positive Allosteric Modulators of the M4 ReceptorBy MSI on September 3, 2014

TRY A LOW-RISK, HIGH-RETURN DRUG DISCOVERY PROJECT

Take advantage of our success-based drug-target characterization services including ortho- and allosteric membrane bound proteins, receptors, ion channels, protein complexes — your toughest targets.
LEARN MORE>
© Copyright 2015 by Molecular Sensing, Inc.
  • /Terms of Use
  • /Privacy Policy